Redefine What It Means to Live with a Rare Disease

We pioneered complement biology, spurring new treatments for devastating disorders. We work to advance healthcare through innovative diagnostics and proactive transparency.

Content from this campaign

Philanthropy & Cause Initiatives

Alexion Charitable Foundation Announces First Rare Belonging® Grants
The Alexion Charitable Foundation, launched by Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in February 2020, has announced it has awarded a total of $1.1 million in initial grants that align with its Rare Belonging® focus. Rare Belonging seeks to...

More from Alexion Pharmaceuticals

  1. Serve Communities and Sustain Our Planet
    We invest in our communities and shared planet in support of those who depend on us today and for generations that follow.

  2. CSR at Alexion
    At Alexion, CSR-STAR supports our mission to transform the lives of people affected by rare and devastating diseases while creating value for all our...

  3. Advance Our People and Our Company
    We aspire to become the most rewarding company to work for, embracing belonging, and governing and managing our business to return value to our...

  4. Ethics and Compliance: Our Foundation
    We build trust when we make the right choices and act with integrity. Our unwavering commitment to ethics, quality and compliance improves our ability...

  5. Redefine What It Means to Live with a Rare Disease
    We pioneered complement biology, spurring new treatments for devastating disorders. We work to advance healthcare through innovative diagnostics and...

  6. Transform Patient Lives
    We urgently seek to understand patient journeys, find answers, and collaborate to deliver access to therapies that change lives.